[ET Net News Agency, 20 October 2021] ALI HEALTH (00241) rose 5.22% to HK$11.7,
breaking above the 50-D SMA of HK$11.699.
It hits an intra-day high of HK$11.7, and an intra-day low of HK$11.3. The total shares
traded was 11.95 million, with a value of HK$137.48m. The active buy/sell ratio is 62:38,
with net buying turnover of HK$32.79m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$9.49m, with volume weighted average price of HK$11.492.
UBS SEC accounts for greatest net responsive selling turnover of HK$10.79m, with volume
weighted average price of HK$11.496. The stock has risen a combined 10.8% over the past 2
consecutive trading days.
The Hang Seng Index now rose 246 points, or 0.95% to 26,033; the Hang Seng China
Enterprises Index now rose 101 points, or 1.11% to 9,237; the Hang Seng TECH Index now
rose 123 points, or 1.9% to 6,642; with an overall turnover of HK$65.31b.
The SSE Composite Index now fell 11 points, or 0.33% to 3,581, with an overall turnover
of RMB222.17b.
The SZSE Component Index now fell 12 points, or 0.08% to 14,487, with an overall
turnover of RMB132.34b.
Basic Information
=================
----------------------------------
Nominal 11.700 % Chg +5.22%
High 11.700 Low 11.300
Shares Tr 11.95m Turnover 137.48m
10-D SMA 10.956 %H.V 60.086
20-D SMA 11.128 VWAP 11.508
50-D SMA 11.699 RSI14 53.406
----------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 62:38, with net buying
turnover of HK$32.79m, rising a combined 10.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 11.700 +5.22
WANJIA GROUP (00401) 0.129 Unchanged
SINOPHARM (01099) 21.300 -1.84
KINGWORLD (01110) 0.750 Unchanged
PIONEER PHARM (01345) 1.260 +1.61
TONGRENTANGCM (03613) 10.180 -1.93
JD HEALTH (06618) 75.950 +2.08
SINCO PHARMA (06833) 0.720 -1.37
---------------------------------------------
(ed)